Literature DB >> 3530590

Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction.

J Fajardo, J M López-Novoa.   

Abstract

The effect of renal selective chemical sympathectomy by intrarenal infusion of 6-hydroxydopamine (6-OHDA, 5 mg/kg body weight) on the renal excretion of water and electrolytes was studied in 7 dogs in whom a syndrome of sodium and water retention and ascites formation was induced by partial constriction of thoracic inferior vena cava. Propranolol (1 mg) and phentolamine (3 mg) were also injected to obviate acute systemic hemodynamic changes. Sympathectomy was performed once in 4 dogs and three times in 3 dogs. Sympathectomy induced an abrupt and transient increase in urinary flow (from 170 +/- 30 to 890 +/- 60 ml/24 h) and sodium excretion (from 4.5 +/- 1.5 to 178 +/- 21 mEq/24 h). This was accompanied by an important fall in plasma renin activity (from 2.2 +/- 0.2 to 0.5 +/- 0.1 ng angiotensin I/ml/h) and aldosterone, and disappearance of ascites. It is concluded that chemical sympathectomy, by increasing renal sodium and water excretion, mobilizes the ascites induced by chronic caval constriction, a fact that highlights the role of the renal sympathetic system in the pathogenesis of sodium and water retention by the kidney.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530590

Source DB:  PubMed          Journal:  Clin Physiol Biochem        ISSN: 0252-1164


  2 in total

1.  Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience.

Authors:  G Simonetti; A Spinelli; R Gandini; V Da Ros; E Gaspari; I Coco; M De Francesco; D Santucci; N Di Daniele; R Lauro
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

Review 2.  Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Authors:  Markus P Schlaich; Henry Krum; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.